Provectus Biopharmaceuticals Inc. Reports Fourth Quarter And Year End 2014 Results
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), today announced its results of operations and financial condition for the fourth quarter and year ended December 31, 2014.
Provectus will also hold its year-end quarterly business update conference call at 4 p.m. (EDT) today to provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.
Help employers find you! Check out all the jobs and post your resume.
Provectus will also hold its year-end quarterly business update conference call at 4 p.m. (EDT) today to provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.
Help employers find you! Check out all the jobs and post your resume.